The effective and efficient management of cancer patients relies upon early diagnosis and/or
the monitoring of treatment, something that is often difficult to achieve using standard tissue …

Hepatocellular carcinoma (HCC), with its high incidence and mortality rate, is one of the
most common malignant tumors. Despite recent development of a diagnostic and treatment …

The field of extracellular vesicles has been rapidly developing after it became evident that a
defined subset of vesicles, called exosomes, can modulate several biological functions in …

Hepatocellular carcinoma (HCC) is one of the common lethal types of tumor all over the
world. The lethality of HCC accounts for many reasons. One of them, the lack of reliable …

Hepatocellular Carcinoma (HCC) is one of the most common malignant tumors with high
incidence and mortality rate. Precision and effective biomarkers are therefore urgently …

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths
worldwide. HCC is diagnosed in its advanced stage when limited treatment options are …

Simple Summary Hepatocellular carcinoma (HCC) is one of the mostly lethal cancers, with a
prognosis which is still very poor. Novel reliable biomarkers, useful in early diagnosis and …

Hepatocellular carcinoma (HCC) represents the sixth most common cancer worldwide and
the third most common cause of cancer-related death. One of the major problems faced by …

Hepatocellular carcinoma (HCC) is known as one of the major health problems worldwide.
Pathological analysis indicated that a variety of risk factors including genetical (ie, alteration …

Hepatocellular carcinoma (HCC) is the third and the fifth leading cause of cancer related
death worldwide in men and in women, respectively. HCC generally has a poor prognosis …